Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The color(s) purple, red is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of The stylized word XCOPRI is in purple upper case letters. The letter "O" contains a red circular design divided by a triangular
ray, which extends past the letter "O." The remaining color white represents background and is not a feature of the mark.
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
930 x 254
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
SK BIOPHARMACEUTICALS CO., LTD.
*STREET
221, Pangyoyeok-ro, Bundang-gu
*CITY
Seongnam-si
*COUNTRY
Korea, South
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
13494
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Korea, South
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Medicines for human purposes and veterinary preparations for treatment of central nervous system diseases, cancer and metabolic diseases;
sanitary preparations for medical use; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biochemical
preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the
treatment of central nervous system diseases, cancer and metabolic diseases; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system
diseases, cancer and metabolic diseases; ferments for pharmaceutical purposes; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer
and metabolic diseases; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or
veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity
adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases;
chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; bacteriological preparations for medical and veterinary use; blood solvent,
namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets.
FILING BASIS
SECTION 1(b)
FILING BASIS
SECTION 44(d)
FOREIGN APPLICATION NUMBER
40-2019-0096170
FOREIGN APPLICATION
COUNTRY
Korea, South
FOREIGN FILING DATE
06/21/2019
INTENT TO
PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ADDITIONAL STATEMENTS SECTION
MISCELLANEOUS STATEMENT
SK BIOPHARMACEUTICALS CO., LTD. is a corporation organized under the laws of the Republic of Korea.
ATTORNEY INFORMATION
NAME
Diane J. Mason
FIRM NAME
Drinker Biddle & Reath LLP
STREET
Four Embarcadero Center, 27th Floor
CITY
San Francisco
STATE
California
COUNTRY
United States
ZIP/POSTAL CODE
94111
PHONE
415-591-7506
EMAIL ADDRESS
sftrademarks@dbr.com
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
OTHER APPOINTED ATTORNEY
Diane J. Mason
CORRESPONDENCE INFORMATION
NAME
Diane J. Mason
FIRM NAME
Drinker Biddle & Reath LLP
STREET
Four Embarcadero Center, 27th Floor
CITY
San Francisco
STATE
California
COUNTRY
United States
ZIP/POSTAL CODE
94111
PHONE
415-591-7506
*EMAIL ADDRESS
sftrademarks@dbr.com; sftrademarks@dbr.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS RF
NUMBER OF CLASSES
1
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEE DUE
275
*TOTAL FEE PAID
275
SIGNATURE INFORMATION
SIGNATURE
/djm/
SIGNATORY'S NAME
Diane J. Mason
SIGNATORY'S POSITION
Attorney of Record, California Bar
SIGNATORY'S PHONE NUMBER
415-591-7506
DATE SIGNED
06/21/2019
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88484180
Filing Date:06/21/2019
To the Commissioner for Trademarks:
MARK: XCOPRI (stylized and/or with design, see mark)
The literal element of the mark consists of XCOPRI.
The color(s) purple, red is/are claimed as a feature of the mark. The mark consists of The stylized word XCOPRI is in purple upper case letters. The letter "O" contains a red circular design divided
by a triangular ray, which extends past the letter "O." The remaining color white represents background and is not a feature of the mark.
The applicant, SK BIOPHARMACEUTICALS CO., LTD., a corporation of Korea, South, having an address of
221, Pangyoyeok-ro, Bundang-gu
Seongnam-si 13494
Korea, South
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Medicines for human purposes and veterinary preparations for treatment of central nervous system diseases, cancer and metabolic
diseases; sanitary preparations for medical use; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biochemical
preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the
treatment of central nervous system diseases, cancer and metabolic diseases; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system
diseases, cancer and metabolic diseases; ferments for pharmaceutical purposes; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer
and metabolic diseases; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or
veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity
adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases;
chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; bacteriological preparations for medical and veterinary use; blood solvent,
namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Korea, South application number 40-2019-0096170, filed 06/21/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
Miscellaneous Statement
SK BIOPHARMACEUTICALS CO., LTD. is a corporation organized under the laws of the Republic of Korea.
The applicant's current Attorney Information:
Diane J. Mason and Diane J. Mason of Drinker Biddle & Reath LLP Four Embarcadero Center, 27th Floor
San Francisco, California 94111
United States
415-591-7506(phone)
sftrademarks@dbr.com (authorized)
The applicant's current Correspondence Information:
Diane J. Mason
Drinker Biddle & Reath LLP
Four Embarcadero Center, 27th Floor
San Francisco, California 94111
415-591-7506(phone)
sftrademarks@dbr.com;sftrademarks@dbr.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /djm/ Date: 06/21/2019
Signatory's Name: Diane J. Mason
Signatory's Position: Attorney of Record, California Bar
Payment Sale Number: 88484180
Payment Accounting Date: 06/24/2019
Serial Number: 88484180
Internet Transmission Date: Fri Jun 21 18:20:13 EDT 2019
TEAS Stamp: USPTO/BAS-XX.XX.XX.X-2019062118201363663
5-88484180-620dd584c2d6c2f3dc1a39c1c2255
8fc19e71c2581b7f62ec1d6b4a569b5de571c-CC
-5013-20190621165133895353